Human PICSAR CRISPR gRNA in Lenti Particles
This is a P38 inhibited cutaneous squamous cell carcinoma associated lincRNA plasmid with gRNA insert cloned into Lentiviral VectorpLenti-U6-sgRNA-PGK-Neo. Insert length: not_set. Stable, Transient expression. Suitable for GEEN and PExp.
Bacterial selection: Ampicillin.
Catalog No. ABIN5182827
$1,511.06
Plus shipping costs $50.00, if applicable $20.00 dry ice
3 x 300 μL
Shipping to:
United States
Delivery in 31 to 41 Business Days
Quick Overview for Human PICSAR CRISPR gRNA in Lenti Particles (ABIN5182827)
Gene
PICSAR
(P38 inhibited cutaneous squamous cell carcinoma associated lincRNA (PICSAR))
Application
Genome Editing with Engineered Nucleases (GEEN), Protein Expression (PExp)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Set of 3 gRNA against NCRNA00162 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- Sequence available upon placing order
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of NCRNA00162
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- PICSAR (P38 inhibited cutaneous squamous cell carcinoma associated lincRNA (PICSAR))
-
Alternative Name
- NCRNA00162
-
NCBI Accession
- NR_024089
Target
-
You are here:
